Complete genome sequence of subsp. BI040, a probiotic strain with multiple health benefits from the NORDBIOTIC collection.

The complete genome of subsp. BI040-a human stool isolate, was sequenced using Illumina and Oxford Nanopore technologies. The BI040 genome is composed of a circular 1,944,141-bp chromosome which carries genes potentially involved in vitamin synthesis and gut health.

Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome-A Randomized, Double-Blind, Placebo-Controlled Study.

Biotics are increasingly being used in the treatment of irritable bowel syndrome (IBS). This study aimed to assess the efficacy and safety of a mixture of microencapsulated sodium butyrate, probiotics ( DSM 26357, DSM 32418, DSM 32946, DSM 32403, and DSM 32269), and short-chain fructooligosaccharides (scFOSs) in IBS patients. This was a randomized, double-blind, placebo-controlled trial involving 120 adult participants with IBS.

Complete genome sequence of LU150, a potential vitamin B producer from the NORDBIOTIC collection.

We performed whole-genome sequencing of LU150, a human fecal isolate from the NORDBIOTIC collection. The genome consists of 2,039,406 bp with a GC content of 38.9%.

The Effect of LPC100 and LP140 on Bone Mineral Density in Postmenopausal Women: A Multicenter, Randomized, Placebo-Controlled Study.

modulation of gut microbiota by probiotics has been proposed as a target for intervention to reduce bone mineral density (BMD) loss in the postmenopausal period. This study aims to evaluate the effect of (L.) LPC100 and (L.

Complete genome sequence of a potentially probiotic cheese isolate LP140 from the Nordbiotic collection.

We report the complete genome sequence of LP140, a cheese isolate from the Nordbiotic collection, comprising 3,371,266 bp with 44.4% GC content. Our data provide insight into the potential of LP140 for use as a probiotic strain.